Total health expenditures in the developing regions of the world willincrease at an annual rate of 9% to reach $539 billion in 2004, according to a new report from US market research firm The Freedonia Group.
Outpatient care will account for the fastest spending growth, based on expanding preventive health activities and increasing levels of private health insurance for physician care. Hospital care will continue to absorb the largest share of expenditures, due to rising admissions and the more cost-intensive nature of in-patient services, the report notes.
Above-average growth in pharma spending is forecast
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze